In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $25.96 for the day, up 4.42% from the previous closing price of $24.86. In other words, the price has increased by $4.42 from its previous closing price. On the day, 0.61 million shares were traded. AKRO stock price reached its highest trading level at $26.25 during the session, while it also had its lowest trading level at $24.655.
Ratios:
Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.89 and its Current Ratio is at 24.89. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 01 ’24 when Young Jonathan sold 5,000 shares for $26.75 per share. The transaction valued at 133,756 led to the insider holds 241,854 shares of the business.
White William Richard sold 139,083 shares of AKRO for $3,753,041 on Jul 24 ’24. The Chief Financial Officer now owns 41,791 shares after completing the transaction at $26.98 per share. On Jul 25 ’24, another insider, White William Richard, who serves as the Chief Financial Officer of the company, sold 22,272 shares for $27.61 each. As a result, the insider received 614,820 and left with 41,791 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1802423552 and an Enterprise Value of 1078495360.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $53.77, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 5.57%, while the 200-Day Moving Average is calculated to be 17.28%.
Shares Statistics:
AKRO traded an average of 783.41K shares per day over the past three months and 430710 shares per day over the past ten days. A total of 69.43M shares are outstanding, with a floating share count of 58.03M. Insiders hold about 16.42% of the company’s shares, while institutions hold 95.55% stake in the company. Shares short for AKRO as of 1722384000 were 6931324 with a Short Ratio of 8.85, compared to 1719532800 on 6467326. Therefore, it implies a Short% of Shares Outstanding of 6931324 and a Short% of Float of 10.31.
